Virtual Conference on retroviruses and opportunistic infections (CROI) held on March 6-10, 2021

  1. UeaphongsukkitT, Gatechompol S, Sophonphan J, Kerr SJ, Lwin HMS, Han WM, Ubolyam S, Chaiyahong P, Phothidokmai C, Cho YS, Shin JG, Avihingsanon A. Efficacy and PK of dolutegravir 50 mg QD with food versus 50 mg BID with rifampicin. (Science Spotlight)
  2. Solomon SS, Wagner-Cardoso S, Smeaton LM, Sowah L, Wimbish C, Robbins G, Brates I, Cheinquer N, Avihingsanon A, Anthony D, Linas B, Naggie S, Wyles D, Sulkowski S. A simple and safe approach to HCV treatment: findings from the A5360 (MINMON) trial. (oral presentation)
  3. Gupta A, Hughes M, Leon-Cruz JT, Avihingsanon A, Mwelase N, Severe P, Ormoz-Oarhe A, Masheto G, Moran L, Benson CA, Chiasson RE, Swindells S. Adverse pregnancy outcomes among HIV-infected women exposed to isoniazid in BRIEF-TB. (oral presentation)